Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

iCura Diagnostics, LLC / COVID-19 Antigen Rapid Home Test Over the Counter Rapid Antigen Self-Test for Detection of SARS-CoV-2 Virus: Clinical Evaluation

NCT05555030 is registered in ClinicalTrials.gov with New Day Diagnostics as lead sponsor.

NCT NCT05555030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05555030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
iCura Diagnostics, LLC / COVID-19 Antigen Rapid Home Test Over the Counter Rapid Antigen Self-Test for Detection of SARS-CoV-2 Virus: Clinical Evaluation
Lead sponsor
New Day Diagnostics
Phase
Not applicable
Overall status
Completed
Start date
August 4, 2022
Completion date
December 20, 2022
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2 infection